Effectiveness of aerobic exercises in menstrual migraine
Trial Snapshot
- Phase
- Phase 2/3
- Status
- Completed
- Sponsor
- Enrollment
- 36
- Locations
- 1
- Primary Endpoint
- Menstrual migraine scale
Study Overview
Brief Summary
Summery:This study is a randomized, experimental, parallel-group, single-center trial assessing the effectiveness of aerobic exercises in menstrual migraine. Additionally, it compares the effectiveness of aerobic exercises and lifestyle modification in managing menstrual migraine. The trial will be conducted at Dayananda Sagar University, Harohalli, over six months, involving adult participants aged 19–40 years diagnosed with menstrual migraine. Participants (n=36) will be randomly assigned to either the aerobic exercise group (n= 18) or the lifestyle modification group(n=18) for 8 weeks. The primary outcome measures will be the Numeric Pain Rating Scale (NPRS) and the Menstrual Migraine Scale at the beginning and end of the study. Secondary outcomes will include the Headache Disability Index before and after intervention . The inclusion criteria include adults (19–40 years) experiencing menstrual migraine with a Menstrual Migraine Scale score above 20 and willingness to provide informed consent. Exclusion criteria include pre-diagnosed migraines of other types, pregnancy, lactation, and any pre-existing conditions. The sample size is yet to be determined.
Study Design
- Study Type
- Interventional
- Allocation
- Coin toss, Lottery, toss of dice, shuffling cards etc
- Masking
- Participant Blinded
Eligibility Criteria
- Ages
- 19.00 Year(s) to 40.00 Year(s) (—)
- Sex
- Female
Inclusion Criteria
- •Headache during mensuration score above menstrual migraine scale females willing to participate in the study and sign informed consent form.
Exclusion Criteria
- •Diagnosed with other type of Migraine Pregnant or Lactating women Any preexisting medical conditions.
Outcomes
Primary Outcomes
Menstrual migraine scale
Time Frame: week 1, week 8 and week 12
Numeric Pain Rating Scale (NPRS)
Time Frame: week 1, week 8 and week 12
Secondary Outcomes
- Headache Disability Index(week 1 week 8 & week 12)